MedTrace Logo

A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects

NCT03211143 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2017-11-21

No results posted yet for this study

Summary

A Study to compare Pharmacokinetics, Pharmacodynamics and safety of CKD-381 and D027 in healty subjects

Conditions

  • GERD

Interventions

DRUG

CKD-381

Test drug: CKD-381

DRUG

Nexium

Reference drug: Nexium

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Choon Ok Kim, MD · Clinical Trials center, Yonsei Univ. Health system

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-20
Primary Completion
2017-08-28
Completion
2017-08-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03211143 on ClinicalTrials.gov